Page last updated: 2024-11-03

opc 12759 and Glaucoma

opc 12759 has been researched along with Glaucoma in 1 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research Excerpts

ExcerptRelevanceReference
"There were no significant differences in fluorescein staining between the untreated and glaucoma eyedrop-treated groups; however, rose bengal staining and the number of inflammatory cells in the conjunctiva significantly increased after glaucoma eyedrop treatment."3.85Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits. ( Higashide, T; Kawaguchi, C; Kawaguchi, I; Kobayashi, A; Sakurai, K; Sugiyama, K; Takeji, Y, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawaguchi, I1
Kobayashi, A1
Higashide, T1
Takeji, Y1
Sakurai, K1
Kawaguchi, C1
Sugiyama, K1

Other Studies

1 other study available for opc 12759 and Glaucoma

ArticleYear
Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Alanine; Animals; Conjunctiva; Corneal Diseases; Female; Fluorescein; Glaucoma; Microscopy, Electron

2017